{"cik":1768224,"taxonomy":"us-gaap","tag":"LongTermDebt","label":"Long-term Debt","description":"Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.","entityName":"ARCTURUS THERAPEUTICS HOLDINGS INC.","units":{"USD":[{"end":"2019-12-31","val":15450000,"accn":"0001564590-20-011037","fy":2019,"fp":"FY","form":"10-K","filed":"2020-03-16","frame":"CY2019Q4I"},{"end":"2020-12-31","val":15300000,"accn":"0001564590-21-009872","fy":2020,"fp":"FY","form":"10-K","filed":"2021-03-01","frame":"CY2020Q4I"},{"end":"2021-03-31","val":15300000,"accn":"0001564590-21-026113","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-10","frame":"CY2021Q1I"},{"end":"2021-06-30","val":15300000,"accn":"0001564590-21-042750","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-10","frame":"CY2021Q2I"},{"end":"2021-09-30","val":15300000,"accn":"0001564590-21-055372","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-09","frame":"CY2021Q3I"},{"end":"2021-12-31","val":15300000,"accn":"0001564590-22-007832","fy":2021,"fp":"FY","form":"10-K","filed":"2022-03-01","frame":"CY2021Q4I"},{"end":"2022-03-31","val":15300000,"accn":"0000950170-22-008524","fy":2022,"fp":"Q1","form":"10-Q","filed":"2022-05-09","frame":"CY2022Q1I"},{"end":"2022-06-30","val":15300000,"accn":"0000950170-22-016043","fy":2022,"fp":"Q2","form":"10-Q","filed":"2022-08-09","frame":"CY2022Q2I"},{"end":"2022-09-30","val":13300000,"accn":"0000950170-22-023969","fy":2022,"fp":"Q3","form":"10-Q","filed":"2022-11-09","frame":"CY2022Q3I"}]}}